BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Belli LS, Fondevila C, Cortesi PA, Conti S, Karam V, Adam R, Coilly A, Ericzon BG, Loinaz C, Cuervas-Mons V, Zambelli M, Llado L, Diaz-Fontenla F, Invernizzi F, Patrono D, Faitot F, Bhooori S, Pirenne J, Perricone G, Magini G, Castells L, Detry O, Cruchaga PM, Colmenero J, Berrevoet F, Rodriguez G, Ysebaert D, Radenne S, Metselaar H, Morelli C, De Carlis LG, Polak WG, Duvoux C; ELITA-ELTR COVID-19 Registry. Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study. Gastroenterology 2021;160:1151-1163.e3. [PMID: 33307029 DOI: 10.1053/j.gastro.2020.11.045] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Jaduan SS, Singh SA, Madan K, Gupta S. SARS-CoV-2 infection in Liver Transplant recipients - Immunosuppression is the silver lining? J Clin Exp Hepatol 2021. [PMID: 34305351 DOI: 10.1016/j.jceh.2021.07.005] [Reference Citation Analysis]
2 Choudhary NS, Dhampalwar S, Saraf N, Soin AS. Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation. J Clin Exp Hepatol 2021. [PMID: 33994708 DOI: 10.1016/j.jceh.2021.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Neurath MF. COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34188251 DOI: 10.1038/s41575-021-00480-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kulkarni AV, Tevethia HV, Premkumar M, Arab JP, Candia R, Kumar K, Kumar P, Sharma M, Rao PN, Reddy DN. Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis. EClinicalMedicine 2021;38:101025. [PMID: 34278287 DOI: 10.1016/j.eclinm.2021.101025] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Ekpanyapong S, Bunchorntavakul C, Reddy KR. COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later. J Viral Hepat 2021. [PMID: 34352133 DOI: 10.1111/jvh.13590] [Reference Citation Analysis]
6 Tseng HT, Wu XC, Huang CY, Shih CM, Lin YW, Lin FY. The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19. Pharmaceuticals (Basel) 2021;14:1054. [PMID: 34681278 DOI: 10.3390/ph14101054] [Reference Citation Analysis]
7 Dęborska-Materkowska D, Kamińska D. The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients. Viruses 2021;13:1879. [PMID: 34578460 DOI: 10.3390/v13091879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Rodríguez-Perálvarez M, Colmenero J, Salcedo M; Spanish Society of Liver Transplantation (SETH). Reply to: "Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients". J Hepatol 2021;75:228-9. [PMID: 33862040 DOI: 10.1016/j.jhep.2021.04.005] [Reference Citation Analysis]
9 Zhou B, Li S, Ye J, Liu Y, Hu L, Tang Y, Wu Z, Zhang P. Immunopathological events surrounding IL-6 and IFN-α: A bridge for anti-lupus erythematosus drugs used to treat COVID-19. Int Immunopharmacol 2021;101:108254. [PMID: 34710657 DOI: 10.1016/j.intimp.2021.108254] [Reference Citation Analysis]
10 Assa A, Benninga MA, Borrelli O, Broekaert I, de Carpi JM, Saccomani MD, Dolinsek J, Mas E, Miele E, Thomson M, Tzivinikos C; Gastrointestinal Committee of ESPGHAN. Gastrointestinal Perspective of Coronavirus Disease 2019 in Children-An Updated Review. J Pediatr Gastroenterol Nutr 2021;73:299-305. [PMID: 34117195 DOI: 10.1097/MPG.0000000000003204] [Reference Citation Analysis]
11 Caballero-Marcos A, Salcedo M, Alonso-Fernández R, Rodríguez-Perálvarez M, Olmedo M, Graus Morales J, Cuervas-Mons V, Cachero A, Loinaz-Segurola C, Iñarrairaegui M, Castells L, Pascual S, Vinaixa-Aunés C, González-Grande R, Otero A, Tomé S, Tejedor-Tejada J, Álamo-Martínez JM, González-Diéguez L, Nogueras-Lopez F, Blanco-Fernández G, Muñoz-Bartolo G, Bustamante FJ, Fábrega E, Romero-Cristóbal M, Martin-Mateos R, Del Rio-Izquierdo J, Arias-Milla A, Calatayud L, Marcacuzco-Quinto AA, Fernández-Alonso V, Gómez-Gavara C, Colmenero J, Muñoz P, Pons JA; Spanish Society of Liver Transplantation (SETH). Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients. Am J Transplant 2021;21:2876-84. [PMID: 33835707 DOI: 10.1111/ajt.16599] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
12 Efe C, Wahlin S. Letter to the Editor: Reply to Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use. Hepatol Commun 2021. [PMID: 34558846 DOI: 10.1002/hep4.1798] [Reference Citation Analysis]
13 Kirchner T, Jaeckel E, Falk CS, Eiz-Vesper B, Taubert R. SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis. J Hepatol 2021;75:1506-9. [PMID: 34284030 DOI: 10.1016/j.jhep.2021.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Loinaz-Segurola C, Marcacuzco-Quinto A, Fernández-Ruiz M. Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects. World J Hepatol 2021; 13(10): 1299-1315 [PMID: 34786167 DOI: 10.4254/wjh.v13.i10.1299] [Reference Citation Analysis]
15 Nicastro E, Verdoni L, Bettini LR, Zuin G, Balduzzi A, Montini G, Biondi A, D'Antiga L. COVID-19 in Immunosuppressed Children. Front Pediatr 2021;9:629240. [PMID: 33996683 DOI: 10.3389/fped.2021.629240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Belli LS, Conti S, Polak W. Reply. Gastroenterology 2021;161:731-2. [PMID: 33891952 DOI: 10.1053/j.gastro.2021.04.033] [Reference Citation Analysis]
17 Ertosun MG, Özkan Ö, Darbaş Ş, Özel D, Bilge U, Sayin Ekinci N, Yilmaz VT, Uçar F, Koçak H, Özkan Ö. The relationship between COVID-19 and HLA in kidney transplant recipients, an evaluation of predictive and prognostic factors. Clin Transplant 2021;:e14525. [PMID: 34726292 DOI: 10.1111/ctr.14525] [Reference Citation Analysis]
18 Scharringa S, Hoffman T, van Kessel DA, Rijkers GT. Vaccination and their importance for lung transplant recipients in a COVID-19 world. Expert Rev Clin Pharmacol 2021;:1-13. [PMID: 34328054 DOI: 10.1080/17512433.2021.1961577] [Reference Citation Analysis]
19 Solanich X, Antolí A, Rocamora-Blanch G, Padullés N, Fanlo-Maresma M, Iriarte A, Mitjavila F, Capdevila O, Riera-Mestre A, Bas J, Vicens-Zygmunt V, Niubó J, Calvo N, Bolivar S, Rigo-Bonnin R, Mensa-Vilaró A, Arregui L, Tebe C, Videla S, Hereu P, Corbella X. Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial. Front Med (Lausanne) 2021;8:691712. [PMID: 34195214 DOI: 10.3389/fmed.2021.691712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Kawazoe M, Kihara M, Nanki T. Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists. Pharmaceuticals (Basel) 2021;14:1256. [PMID: 34959657 DOI: 10.3390/ph14121256] [Reference Citation Analysis]
21 Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Aldana AJG, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu-Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Zazueta GM, Demirezer-Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Narro GC, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Reyes EC, Harputluoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Vargas NCE, Güzelbulut F, Garcia SR, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, N Assis D, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. Liver Int 2021. [PMID: 34846800 DOI: 10.1111/liv.15121] [Reference Citation Analysis]
22 Kidson KM, Park J, Charles MK, Omar M, Krajden M, Wright AJ, Hussaini T, Kim PTW, Chung SW, Yoshida EM. Successful Liver Transplantation in a Patient With Acute COVID-19 Infection and Acute Liver Failure: A Case Report. Transplant Direct 2021;7:e747. [PMID: 34476292 DOI: 10.1097/TXD.0000000000001210] [Reference Citation Analysis]
23 Delgado-Fernández M, García-Gemar GM, Fuentes-López A, Muñoz-Pérez MI, Oyonarte-Gómez S, Ruíz-García I, Martín-Carmona J, Sanz-Cánovas J, Castaño-Carracedo MÁ, Reguera-Iglesias JM, Ruíz-Mesa JD. Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency - Three consecutive cases and review of the literature. Enferm Infecc Microbiol Clin (Engl Ed) 2021:S0213-005X(21)00035-5. [PMID: 33741148 DOI: 10.1016/j.eimc.2021.01.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
24 Quante M, Brake L, Tolios A, Della Penna A, Steidle C, Gruendl M, Grishina A, Haeberle H, Guthoff M, Tullius SG, Königsrainer A, Nadalin S, Löffler MW. SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020. Transplant Proc 2021;53:2421-34. [PMID: 34551880 DOI: 10.1016/j.transproceed.2021.08.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Gato S, Lucena-Valera A, Muñoz-Hernández R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021; 10(6): 301-311 [PMID: 34909404 DOI: 10.5501/wjv.v10.i6.301] [Reference Citation Analysis]
26 Søfteland JM, Friman G, von Zur-Mühlen B, Ericzon BG, Wallquist C, Karason K, Friman V, Ekelund J, Felldin M, Magnusson J, Haugen Löfman I, Schult A, de Coursey E, Leach S, Jacobsson H, Liljeqvist JÅ, Biglarnia AR, Lindnér P, Oltean M. COVID-19 in solid organ transplant recipients: A national cohort study from Sweden. Am J Transplant 2021;21:2762-73. [PMID: 33811777 DOI: 10.1111/ajt.16596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
27 Russo FP, Izzy M, Rammohan A, Kirchner VA, Di Maira T, Belli LS, Berg T, Berenguer MC, Polak WG. Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS). J Hepatol 2021:S0168-8278(21)02107-3. [PMID: 34653592 DOI: 10.1016/j.jhep.2021.09.041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Vitale G, Gitto S, Marra F, Morelli MC. From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic. Intern Emerg Med 2021. [PMID: 34245423 DOI: 10.1007/s11739-021-02801-0] [Reference Citation Analysis]
29 Alberca RW, Benard G, Alberca GGF, Sato MN. SARS-CoV-2 infection in liver transplant recipients: A complex relationship. World J Gastroenterol 2021; 27(44): 7734-7738 [PMID: 34908810 DOI: 10.3748/wjg.v27.i44.7734] [Reference Citation Analysis]
30 Kehar M, Ebel NH, Ng VL, Baquero JER, Leung DH, Slowik V, Ovchinsky N, Shah AA, Arnon R, Miloh T, Gupta N, Mohammad S, Kogan-Liberman D, Squires JE, Sanchez MC, Hildreth A, Book L, Chu C, Alrabadi L, Azzam R, Chepuri B, Elisofon S, Falik R, Gallagher L, Kader H, Mogul D, Mujawar Q, Namjoshi SS, Valentino PL, Vitola B, Waheed N, Zheng MH, Lobritto S, Martinez M. Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children With Liver Transplant and Native Liver Disease: An International Observational Registry Study. J Pediatr Gastroenterol Nutr 2021;72:807-14. [PMID: 33605666 DOI: 10.1097/MPG.0000000000003077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
31 Thuluvath PJ, Robarts P, Chauhan M. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases. J Hepatol 2021;75:1434-9. [PMID: 34454993 DOI: 10.1016/j.jhep.2021.08.008] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
32 Pearson MM, Limaye AP, Biggins SW. Tacrolimus: Unlikely Harmful and Perhaps Helpful in Liver Transplant Recipients with COVID-19. Gastroenterology. 2021;160:1012-1013. [PMID: 33387518 DOI: 10.1053/j.gastro.2020.12.050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Ruiz I. Beneficial Effect of Tacrolimus… Cyclosporin A, Still up for Discussion! Gastroenterology 2021;161:730-1. [PMID: 33631182 DOI: 10.1053/j.gastro.2021.02.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 De Carlis R, Vella I, Incarbone N, Centonze L, Buscemi V, Lauterio A, De Carlis L. Impact of the COVID-19 pandemic on liver donation and transplantation: A review of the literature. World J Gastroenterol 2021; 27(10): 928-938 [PMID: 33776364 DOI: 10.3748/wjg.v27.i10.928] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
35 Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, Barnes E. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 2021;18:348-64. [PMID: 33692570 DOI: 10.1038/s41575-021-00426-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 27.0] [Reference Citation Analysis]
36 Yin S, Wang X, Song T. Tacrolimus Use and COVID-19 Infection in Patients After Solid Organ Transplantation. Gastroenterology 2021;161:728-730.e1. [PMID: 33539863 DOI: 10.1053/j.gastro.2021.01.223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Kuczborska K, Książyk J. Prevalence and Course of SARS-CoV-2 Infection among Immunocompromised Children Hospitalised in the Tertiary Referral Hospital in Poland. J Clin Med 2021;10:4556. [PMID: 34640570 DOI: 10.3390/jcm10194556] [Reference Citation Analysis]
38 Phipps MM, Verna EC. Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic. Liver Transpl 2021;27:1312-25. [PMID: 34096188 DOI: 10.1002/lt.26194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
40 Gupta R, Gupta J, Ammar H. Impact of COVID-19 on the outcomes of gastrointestinal surgery. Clin J Gastroenterol 2021;14:932-46. [PMID: 33928515 DOI: 10.1007/s12328-021-01424-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Goldman JD, Robinson PC, Uldrick TS, Ljungman P. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. J Immunother Cancer 2021;9:e002630. [PMID: 34117116 DOI: 10.1136/jitc-2021-002630] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Becchetti C, Broekhoven AGC, Dahlqvist G, Fraga M, Zambelli MF, Ciccarelli O, Saouli AC, Trizzino A, Banz V, Dufour JF, Roukens AHE, Torres Morales SP, Myeni SK, Kikkert M, Feltkamp MCW, Coenraad MJ. Humoral response to SARS-CoV-2 infection among liver transplant recipients. Gut 2022:gutjnl-2021-326609. [PMID: 34987065 DOI: 10.1136/gutjnl-2021-326609] [Reference Citation Analysis]
43 Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID-19 and the liver: A 2021 update. Liver Int 2021;41:1988-98. [PMID: 34152690 DOI: 10.1111/liv.14984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Magro F, Nuzzo A, Abreu C, Libânio D, Rodriguez-Lago I, Pawlak K, Hollenbach M, Brouwer WP, Siau K. COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology. United European Gastroenterol J 2021. [PMID: 34190413 DOI: 10.1002/ueg2.12115] [Reference Citation Analysis]
45 Magnusson JM, Larsson H, Alsaleh A, Ekelund J, Karason K, Schult A, Friman V, Felldin M, Søfteland JM, Dellgren G, Oltean M. COVID-19 in lung transplant recipients: an overview of the Swedish national experience. Transpl Int 2021. [PMID: 34709680 DOI: 10.1111/tri.14148] [Reference Citation Analysis]
46 Zaky S, Alboraie M, El Badry M, Metwally MA, Abdelaziz A, Fouad Y, Abd-Elsalam S, Mahmoud A, Shiha G, Baki AA, El Kassas M, Esmat G. Management of liver disease patients in different clinical situations during COVID-19 pandemic. Egypt Liver J 2021;11:21. [PMID: 34777868 DOI: 10.1186/s43066-021-00091-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Becchetti C, Gschwend SG, Dufour JF, Banz V. COVID-19 in Liver Transplant Recipients: A Systematic Review. J Clin Med 2021;10:4015. [PMID: 34501463 DOI: 10.3390/jcm10174015] [Reference Citation Analysis]
48 Betjes MGH. Uremia-Associated Immunological Aging and Severity of COVID-19 Infection. Front Med (Lausanne) 2021;8:675573. [PMID: 33937299 DOI: 10.3389/fmed.2021.675573] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Vyhmeister R, Enestvedt CK, VanSandt M, Schlansky B. Steroid-Resistant Acute Cellular Rejection of the Liver After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination. Liver Transpl 2021;27:1339-42. [PMID: 33993619 DOI: 10.1002/lt.26097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]